Xenon Announces Azetukalner NDA Submission to FDA for Focal Seizures and Provides Update on Psychiatry Clinical Program

New Drug Application for azetukalner in focal seizures submitted to U.S. Food and Drug Administration; X-TOLE3 and X-ACKT continue to enroll focal seizure and PGTCS patients, respectively Enrollment in X-NOVA2 study in MDD completed with approximately 360 total patients; topline data readout expected Q1 2027 The Company has voluntarily initiated a temporary pause of enrollment […]

financialpost.com ·2h ago

We haven't written up this one. Financial Post has the full story — the link below goes straight to it.

Read the original at financialpost.com →

More in Health & Medicine

Researchers explore the hidden pathways linking problematic caffeine use to sleep loss

Researchers recently investigated the pathways connecting caffeine use disorder, depression, and sleep quality. Their findings illustrate how problematic caffeine consumption and specific use motives…

2h ago ·psypost.org

No, insulin still doesn’t cost $35

A decade ago, insulin became the poster child for America’s out-of-control drug prices. The 2017 death of Alec Smith, who was rationing his insulin before he died, and repeated price hikes for a…

2h ago ·vox.com

RFK Jr promises anti-vaxxers a ‘friend at the White House’ amid deadly measles outbreak

The US health secretary added that he would’ve made sweeping changes ‘on day one’ but he had to follow the law As the death toll from the worst measles outbreak in decades rises, Robert F Kennedy Jr…

2h ago ·theguardian.com

7 of the weirdest things coffee does to your body

Coffee doesn’t just make you feel more alert. Here’s what else happens when you drink a cuppa.

Coffee can trigger bowel movements in about one-third of drinkers.
Caffeine may raise eye pressure in glaucoma patients.
Coffee can interfere with the absorption of certain medications.

2h ago ·theconversation.com

Medicare Subsidy Scrapped By Trump Would Be Saved Under New Bill

Representatives Kathy Castor of Florida and Terri Sewell of Alabama unveiled the Affordable Premiums for Seniors Act this week.

The bill aims to extend Medicare Part D Premium Stabilization Demonstration until 2029.
Nearly 25 million Americans enrolled in standalone Medicare Part D plans in 2026.

2h ago ·newsweek.com

Phase 3 Pediatric EMPAVELI Data Published in Clinical Journal of the American Society of Nephrology Show Reduction in Proteinuria and Stabilized Kidney Function in Adolescents with C3G or Primary IC-MPGN

EMPAVELI-treated adolescents achieved a 75% relative reduction in proteinuria within 6 months versus placebo EMPAVELI is the only approved treatment for adolescents with C3G and primary IC-MPGN, based…

2h ago ·financialpost.com